Hypertension, Vol 18, 565-574, Copyright © 1991 by American Heart Association
M Hori and M Kitakaze
Adenosine is known to regulate myocardial and coronary circulatory
functions. Adenosine not only dilates coronary vessels, but attenuates
beta-adrenergic receptor-mediated increases in myocardial contractility and
depresses both sinoatrial and atrioventricular node activities. The effects
of adenosine are mediated by two distinct receptors (i.e., A1 and A2
receptors). A1 adenosine receptors, located in atrial and ventricular
myocardium and sinoatrial/atrioventricular nodes, are responsible for
inhibition of adenylyl cyclase activity. A2 adenosine receptors, located in
coronary endothelial and smooth muscle cells, are responsible for
stimulation of this enzyme activity. During increased myocardial oxygen
demand due to rapid pacing and exercise, although both coronary blood flow
and adenosine concentrations in the myocardium and coronary efflux
increased, there is no clear consensus explaining its cause and effect
relation at present. However, ischemia/reperfusion- induced coronary
hyperemia is believed to be mostly attributed to released adenosine, and it
has been proven that adenosine attenuates the severity of ischemia due to
its coronary vasodilatory action. The beneficial effects of adenosine
during ischemia/reperfusion processes do not seem simple. This is because
myocardial ischemia and reperfusion injury is caused by 1) activated
leukocytes and platelets, 2) ATP depletion and calcium overload of
myocardium, and 3) catecholamine release from the presynaptic nerves as
well as 4) the impaired coronary circulation. Intriguingly adenosine
attenuates all of these deleterious actions and thereby attenuates
ischemia/reperfusion injury. Indeed, adenosine attenuates the severity of
contractile dysfunction (myocardial stunning) and limits the infarct size.
Thus, administration of adenosine or potentiators of adenosine production
in the ischemic myocardium may be beneficial for the attenuation of
ischemic and reperfusion injuries, although further clinical investigations
are necessary.
ARTICLES
Adenosine, the heart, and coronary circulation
First Department of Medicine, Osaka University School of Medicine, Japan.
This article has been cited by other articles:
![]() |
H. R. Ansari, A. Nadeem, M. A. H. Talukder, S. Sakhalkar, and S. J. Mustafa Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H719 - H725. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wakeno, T. Minamino, O. Seguchi, H. Okazaki, O. Tsukamoto, K.-i. Okada, A. Hirata, M. Fujita, H. Asanuma, J. Kim, et al. Long-Term Stimulation of Adenosine A2b Receptors Begun After Myocardial Infarction Prevents Cardiac Remodeling in Rats Circulation, October 31, 2006; 114(18): 1923 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Tawfik, B. Teng, R. R. Morrison, J. Schnermann, and S. J. Mustafa Role of A1 adenosine receptor in the regulation of coronary flow Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H467 - H472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Cornelis, A. El-Sohemy, E. K. Kabagambe, and H. Campos Coffee, CYP1A2 Genotype, and Risk of Myocardial Infarction JAMA, March 8, 2006; 295(10): 1135 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. McNulty, N. King, S. Scott, G. Hartman, J. McCann, M. Kozak, C. E. Chambers, L. M. Demers, and L. I. Sinoway Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1057 - H1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, S. Epperson, L. Makhsudova, B. Ito, J. Suarez, W. Dillmann, and F. Villarreal Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2478 - H2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Happonen, S. Voutilainen, and J. T. Salonen Coffee Drinking Is Dose-Dependently Related to the Risk of Acute Coronary Events in Middle-Aged Men J. Nutr., September 1, 2004; 134(9): 2381 - 2386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. H. Talukder, R. R. Morrison, M. A. Jacobson, K. A. Jacobson, C. Ledent, and S. J. Mustafa Targeted deletion of adenosine A3 receptors augments adenosine-induced coronary flow in isolated mouse heart Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2183 - H2189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. H. Talukder, R. R. Morrison, and S. J. Mustafa Comparison of the vascular effects of adenosine in isolated mouse heart and aorta Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H49 - H57. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Obata, S. Kubota, and Y. Yamanaka Histamine Increases Interstitial Adenosine Concentration via Activation of Ecto-5'-nucleotidase in Rat Hearts in Vivo J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 71 - 76. [Abstract] [Full Text] |
||||
![]() |
J. L. Anderson, J. Habashi, J. F. Carlquist, J. B. Muhlestein, B. D. Horne, T. L. Bair, R. R. Pearson, and N. Hart A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1248 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Suwaidi, S. Hamasaki, S. T. Higano, R. A. Nishimura, D. R. Holmes Jr, and A. Lerman Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction Circulation, March 7, 2000; 101(9): 948 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshida, M. Hirai, T. Yamada, Y. Tsuji, T. Kondo, Y. Inden, M. Akahoshi, Y. Murakami, M. Tsuda, N. Tsuboi, et al. Antiarrhythmic Efficacy of Dipyridamole in Treatment of Reperfusion Arrhythmias : Evidence for cAMP-Mediated Triggered Activity as a Mechanism Responsible for Reperfusion Arrhythmias Circulation, February 15, 2000; 101(6): 624 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Peyot, A.-P. Gadeau, F. Dandre, I. Belloc, F. Dupuch, and C. Desgranges Extracellular Adenosine Induces Apoptosis of Human Arterial Smooth Muscle Cells via A2b-Purinoceptor Circ. Res., January 7, 2000; 86(1): 76 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Flores, B. M. Stavrou, and D. J. Sheridan The effects of diadenosine polyphosphates on the cardiovascular system Cardiovasc Res, April 1, 1999; 42(1): 15 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Loh, T. R. Rebbeck, P. D. Mahoney, D. DeNofrio, J. L. Swain, and E. W. Holmes Common Variant in AMPD1 Gene Predicts Improved Clinical Outcome in Patients With Heart Failure Circulation, March 23, 1999; 99(11): 1422 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kitakaze, K. Node, T. Minamino, H. Asanuma, T. Kuzuya, and M. Hori A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs J. Am. Coll. Cardiol., January 1, 1999; 33(1): 242 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perlini, E. P. Khoury, G. R. Norton, E. S. Chung, R. A. Fenton, J. G. Dobson Jr, and T. E. Meyer Adenosine Mediates Sustained Adrenergic Desensitization in the Rat Heart via Activation of Protein Kinase C Circ. Res., October 5, 1998; 83(7): 761 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Kuzmin, V. L. Lakomkin, V. I. Kapelko, and G. Vassort Interstitial ATP level and degradation in control and postmyocardial infarcted rats Am J Physiol Cell Physiol, September 1, 1998; 275(3): C766 - C771. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Domenech, P. Macho, D. Velez, G. Sanchez, X. Liu, and N. Dhalla Tachycardia Preconditions Infarct Size in Dogs : Role of Adenosine and Protein Kinase C Circulation, March 3, 1998; 97(8): 786 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Minamino, M. Kitakaze, H. Sato, H. Funaya, Y. Ueda, H. Asanuma, T. Kuzuya, and M. Hori Effects of ischemic preconditioning on contractile and metabolic function during hypoperfusion in dogs Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H684 - H693. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hasdai, R. J. Gibbons, D. R. Holmes Jr, S. T. Higano, and A. Lerman Coronary Endothelial Dysfunction in Humans Is Associated With Myocardial Perfusion Defects Circulation, November 18, 1997; 96(10): 3390 - 3395. [Abstract] [Full Text] |
||||
![]() |
H. T. Sommerschild, F. Grund, J. Offstad, P. Jynge, A. Ilebekk, and K. A. Kirkeboen Importance of Endogenous Adenosine During Ischemia and Reperfusion in Neonatal Porcine Hearts Circulation, November 4, 1997; 96(9): 3094 - 3103. [Abstract] [Full Text] |
||||
![]() |
M. Kitakaze, T. Minamino, H. Funaya, K. Node, Y. Shinozaki, H. Mori, and M. Hori Vesnarinone Limits Infarct Size via Adenosine-Dependent Mechanisms in the Canine Heart Circulation, April 15, 1997; 95(8): 2108 - 2114. [Abstract] [Full Text] |
||||
![]() |
H. Funaya, M. Kitakaze, K. Node, T. Minamino, K. Komamura, and M. Hori Plasma Adenosine Levels Increase in Patients With Chronic Heart Failure Circulation, March 18, 1997; 95(6): 1363 - 1365. [Abstract] [Full Text] |
||||
![]() |
T. Minamino, M. Kitakaze, K. Komamura, K. Node, H. Takeda, M. Inoue, M. Hori, and T. Kamada Activation of Protein Kinase C Increases Adenosine Production in the Hypoxic Canine Coronary Artery Through the Extracellular Pathway Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2298 - 2304. [Abstract] [Full Text] |
||||
![]() |
S. A. Rivkees, M. E. Lasbury, and H. Barbhaiya Identification of Domains of the Human A(1) Adenosine Receptor That Are Important for Binding Receptor Subtype-selective Ligands Using Chimeric A(1)/A[IMAGE] Adenosine Receptors J. Biol. Chem., September 1, 1995; 270(35): 20485 - 20490. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Katsuda, K. Egashira, H. Ueno, Y. Akatsuka, T. Narishige, Y. Arai, T. Takayanagi, H. Shimokawa, and A. Takeshita Glibenclamide, a Selective Inhibitor of ATP-Sensitive K+ Channels, Attenuates Metabolic Coronary Vasodilatation Induced by Pacing Tachycardia in Dogs Circulation, August 1, 1995; 92(3): 511 - 517. [Abstract] [Full Text] |
||||
![]() |
M. A. H. Talukder, R. R. Morrison, M. A. Jacobson, K. A. Jacobson, C. Ledent, and S. J. Mustafa Targeted deletion of adenosine A3 receptors augments adenosine-induced coronary flow in isolated mouse heart Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2183 - H2189. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |